Sermorelin Research for Body Composition
An evidence-based overview of research examining Sermorelin in the context of body composition. This page synthesizes findings from peer-reviewed literature.
Research Summary
Clinical trials have consistently shown that sermorelin improves body composition by increasing lean mass and decreasing fat mass in older adults. A 6-month NIH trial demonstrated significant improvements in body composition without major adverse effects.
The 5-month trial by Khorram et al. showed that men receiving GHRH experienced improvements in insulin sensitivity alongside body composition changes, suggesting metabolic benefits beyond simple fat loss.
Swedish research has examined the comparative effects of GH versus GHRH on body composition and bone density, finding that GHRH therapy may offer advantages in preserving physiologic regulation while achieving similar body composition benefits.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Body Composition
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Sermorelin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.